Verastem, Inc.: updates and filings

VSTMNASDAQHealthcare · Pharmaceutical Preparations

Price

$6.86

November 19, 2026Market cap $864M

What Ploutos Investor adds for Verastem

Part of Ploutos Investor, €9.99 a month

See the plans
  • The full history: 7 fiscal years, from 2018
  • The estimated fair value, with its range and its certainty
  • The full analysis, 18 a month
  • More questions to the chat on its filings
  • Excel with every year
  • An email when it reports, changes its dividend or an officer buys

Sign in with a free account to see the last 5 fiscal years.

Notes on these figures

  • The share price has fallen 27% since Nov 5, 2026, when the 10-Q these figures come from was filed ($9.38 then, $6.87 on Nov 18, 2026). The figures date from before that move.10-Q
  • The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.

What comes next, and what happened

Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.

Next results

in 67 daysAround Jan 25, 2027 · for Q4 2026

last Oct 14, 2026next Jan 25, 2027

A rough estimate from when it has reported before, which has varied. The company announces the date itself.

Its SEC filings

What it has filed lately, newest first, linked to the document itself.

Mar 4, 2026 latest annualNov 5, 2026 latest quarterly
  • Nov 19, 2026Officer or director change
    Form8-K
  • Nov 16, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Nov 10, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Nov 5, 2026Shelf registration for future offerings
    FormS-3ASR
  • Nov 5, 2026Shares registered for employees
    FormS-8
  • Nov 5, 2026Regulation FD disclosure
    Form8-K
  • Nov 5, 2026Quarterly reportfor the period to Sep 30, 2026
    Form10-Q
  • Oct 30, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Oct 14, 2026Other material events
    Form8-K
  • Oct 14, 2026Results of operations, officer or director change, Regulation FD disclosure, other material events
    Form8-K
  • Aug 14, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Aug 7, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Aug 7, 2026Material agreement entered, new material financial obligation, Regulation FD disclosure
    Form8-K
  • Aug 6, 2026Results of operations
    Form8-K
  • Aug 6, 2026Quarterly reportfor the period to Jun 30, 2026
    Form10-Q
  • Jul 31, 2026Over-5% holder statement (passive)
    FormSCHEDULE 13G
  • Jul 30, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jul 8, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • Jun 23, 2026Regulation FD disclosure, other material events
    Form8-K
  • Jun 17, 2026Regulation FD disclosure, other material events
    Form8-K
  • May 29, 2026Shares registered for employees
    FormS-8
  • May 26, 2026Shareholder vote
    Form8-K
  • May 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • May 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A
  • May 15, 2026Over-5% holder statement (passive) (amendment)
    FormSCHEDULE 13G/A

From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC, since Jul 26, 2011.

The full analysis

What do Verastem's filings show?

The filings are where every one of Verastem's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.

  • A fair value range built from the filings
  • Earnings quality, debt and red flags
  • Insider and institutional moves
  • The case for and the case against

All filings on EDGAR

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.